RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INCY
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Incyte Corporation stock downgraded after the last trading session.
(Updated on Jul 02, 2024)

Sell candidate since Jul 02, 2024 PDF

The Incyte Corporation stock price fell by -3.04% on the last day (Tuesday, 2nd Jul 2024) from $60.87 to $59.02. During the last trading day the stock fluctuated 3.15% from a day low at $58.63 to a day high of $60.48. The price has fallen in 6 of the last 10 days and is down by -5.85% for this period. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $183.71 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $58.81 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 18.90% during the next 3 months and, with a 90% probability hold a price between $69.93 and $76.98 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INCY Signals & Forecast

There are few to no technical positive signals at the moment. The Incyte Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $61.49 and $59.44. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 24, 2024, and so far it has fallen -7.42%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Incyte Corporation stock

Incyte Corporation finds support from accumulated volume at $58.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.85 between high and low, or 3.15%. For the last week, the stock has had daily average volatility of 2.55%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INCY) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Incyte Corporation to open at $59.38, and during the day (based on 14 day Average True Range), to move between $57.56 and $60.48, which gives a possible trading interval of +/-$1.46 (+/-2.48%) up or down from last closing price. If Incyte Corporation takes out the full calculated possible swing range there will be an estimated 4.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $59.16 (0.24%) than the support at $58.80 (0.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Incyte Corporation stock A Buy?

The Incyte Corporation stock holds several negative signals and despite the positive trend, we believe Incyte Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.804 Sell Candidate Downgraded

Predicted Opening Price for Incyte Corporation of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$59.38 ( 0.605%) $59.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INCY

Fibonacci Support & Resistance Levels

Level Price
R3 61.23 3.74%
R2 60.52 2.54%
R1 60.08 1.80%
Price 59.02
S1 58.67 -0.591%
S2 58.23 -1.33%
S3 57.53 -2.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 63.22 7.12%
R2 62.69 6.22%
R1 59.16 0.237%
Price 59.02
S1 58.80 -0.373%
S2 58.41 -1.03%
S3 57.60 -2.41%

FAQ

What is the symbol for Incyte Corporation Stock and on which exchange is it traded?
The symbol for Incyte Corporation is INCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Incyte Corporation Stock?
The Incyte Corporation stock holds several negative signals and despite the positive trend, we believe Incyte Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Incyte Corporation Stock?
Incyte Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Incyte Corporation Stock.

What's the current price of Incyte Corporation Stock?
As of the end of day on the Jul 02, 2024, the price of an Incyte Corporation (INCY) share was $59.02.

What is the 52-week high and low for Incyte Corporation Stock?
The 52-week high for Incyte Corporation Stock is $67.37 and the 52-week low is $50.27.

What is the market capitalization of Incyte Corporation Stock?
As of the Jul 02, 2024, the market capitalization of Incyte Corporation is 13.687B.

When is the next earnings date for Incyte Corporation?
The upcoming earnings date for Incyte Corporation is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT